β –Blockers in reactive airway disease

Chogtu, Bharti and Magazine, Rahul and Bairy, KL (2011) β –Blockers in reactive airway disease. Journal of Clinical and Diagnostic Research., 5 (2). pp. 414-417.

[img] PDF
Beta.pdf - Published Version
Restricted to Registered users only

Download (156kB) | Request a copy

Abstract

Beta-2- adrenergic agonists agonists are used in the treatment of reversible airway disease. β-blockers, due to their bronchoconstrictor effects, are supposed to be deleterious in such patients. In this review, we are putting forth some recent studies and meta analysis, which indicate that the chronic use of β-blockers in patients with reversible airway disease does not produce pulmonary impairment. Also, these drugs need not be withheld from patients with other diseases like hypertension,after weighing the risk: benefit ratio.

Item Type: Article
Uncontrolled Keywords: β- blockers, COPD, Asthma
Subjects: Medicine > KMC Manipal > Pharmacology
Depositing User: KMC Manipal
Date Deposited: 31 Jan 2012 04:26
Last Modified: 31 Jan 2012 04:26
URI: http://eprints.manipal.edu/id/eprint/2772

Actions (login required)

View Item View Item